REPOSITORI BADAN KEBIJAKAN PEMBANGUNAN KESEHATAN

Uji Disolusi Dan Penetapan Kadar Tablet Loratadin Inovator Dan Generik Bermerek

Raini, Mariana and Mutiatikum, Dahoram (2010) Uji Disolusi Dan Penetapan Kadar Tablet Loratadin Inovator Dan Generik Bermerek. Media Penelitian dan Pengembangan Kesehatan, 20 (2). ISSN 0853-9987

[thumbnail of 783-1042-1-PB.pdf]
Preview
Text
783-1042-1-PB.pdf - Published Version

Download (427kB) | Preview

Abstract

Antihistamines Loratadin available in tablet form, as loratadin tablets innovator, branded generic preparations. Socializing generic drugs need information about quality of these drugs, to ensure that the quality of generic drugs not lower or similar to its innovator drugs. The impact of economic crisis caused the price of very expensive drugs. The information quality of generic drugs is expected to increase the use of generic drugs by health practitioners and public. It is necessary for the laboratory data that are qualityparameters, such as dissolution profiles, dissolution testing and determinationof drug dosage levels. Dissolution test method anddetermination of levelsconducted in accordanceto the requirements of the USP (United State of Pharmacopeia). Loratadin dissolution test resultsof tablets A, B and Cin accordancewith the requirements of the USP. Loratadin contentin tablet Ais 103, 73%, B=99,62% and C=100,21%. Loratadin levels in all of these tablets meet the requirements of the USP.

Item Type: Article
Uncontrolled Keywords: Innovator,Branded Generic Drug, Dissolution, Content
Subjects: QS-QZ Preclinical sciences (NLM Classification) > QV Pharmacology > QV 701-835 Pharmacy and Pharmaceutics
Divisions: Badan Penelitian dan Pengembangan Kesehatan > Badan Penelitian dan Pengembangan Kesehatan
Depositing User: Administrator Eprints
Date Deposited: 02 Oct 2017 05:29
Last Modified: 21 Nov 2017 08:31
URI: https://repository.badankebijakan.kemkes.go.id/id/eprint/1407

Actions (login required)

View Item View Item